FDA Chief Proposes New Pricing Model and Cites New Guidelines to Spur Antibiotic Development

On Tuesday, FDA Commissioner Scott Gottlieb released a statement on the effort to aid much-needed antibiotic development. In the statement, Gottlieb proposed a unique pricing model intended to provide manufacturers with a more predictable market and ROI.